Switch to:
Also traded in: Brazil, Chile, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.13
NYSE:CVS's Cash-to-Debt is ranked lower than
92% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.02 vs. NYSE:CVS: 0.13 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:CVS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09  Med: 0.16 Max: 0.78
Current: 0.13
0.09
0.78
Equity-to-Asset 0.39
NYSE:CVS's Equity-to-Asset is ranked higher than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. NYSE:CVS: 0.39 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:CVS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.39  Med: 0.53 Max: 0.61
Current: 0.39
0.39
0.61
Interest Coverage 9.59
NYSE:CVS's Interest Coverage is ranked lower than
52% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.87 vs. NYSE:CVS: 9.59 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:CVS' s Interest Coverage Range Over the Past 10 Years
Min: 9.59  Med: 11.43 Max: 15.55
Current: 9.59
9.59
15.55
Piotroski F-Score: 5
Altman Z-Score: 3.70
Beneish M-Score: -2.64
WACC vs ROIC
6.15%
10.35%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 5.82
NYSE:CVS's Operating Margin % is ranked higher than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.72 vs. NYSE:CVS: 5.82 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:CVS' s Operating Margin % Range Over the Past 10 Years
Min: 5.82  Med: 6.3 Max: 6.91
Current: 5.82
5.82
6.91
Net Margin % 3.00
NYSE:CVS's Net Margin % is ranked higher than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.45 vs. NYSE:CVS: 3.00 )
Ranked among companies with meaningful Net Margin % only.
NYSE:CVS' s Net Margin % Range Over the Past 10 Years
Min: 3  Med: 3.44 Max: 3.76
Current: 3
3
3.76
ROE % 14.68
NYSE:CVS's ROE % is ranked higher than
65% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.97 vs. NYSE:CVS: 14.68 )
Ranked among companies with meaningful ROE % only.
NYSE:CVS' s ROE % Range Over the Past 10 Years
Min: 9.14  Med: 11.33 Max: 14.68
Current: 14.68
9.14
14.68
ROA % 5.70
NYSE:CVS's ROA % is ranked higher than
72% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.87 vs. NYSE:CVS: 5.70 )
Ranked among companies with meaningful ROA % only.
NYSE:CVS' s ROA % Range Over the Past 10 Years
Min: 5.46  Med: 5.97 Max: 7
Current: 5.7
5.46
7
ROC (Joel Greenblatt) % 69.75
NYSE:CVS's ROC (Joel Greenblatt) % is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 73.37 vs. NYSE:CVS: 69.75 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:CVS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 41.72  Med: 49.64 Max: 69.75
Current: 69.75
41.72
69.75
3-Year Revenue Growth Rate 16.70
NYSE:CVS's 3-Year Revenue Growth Rate is ranked higher than
82% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.60 vs. NYSE:CVS: 16.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:CVS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 7.7  Med: 12.4 Max: 16.7
Current: 16.7
7.7
16.7
3-Year EBITDA Growth Rate 11.80
NYSE:CVS's 3-Year EBITDA Growth Rate is ranked higher than
65% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.40 vs. NYSE:CVS: 11.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:CVS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 2.5  Med: 13.5 Max: 43.7
Current: 11.8
2.5
43.7
3-Year EPS without NRI Growth Rate 9.40
NYSE:CVS's 3-Year EPS without NRI Growth Rate is ranked higher than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. NYSE:CVS: 9.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:CVS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 1.7  Med: 15.2 Max: 112.8
Current: 9.4
1.7
112.8
GuruFocus has detected 1 Warning Sign with CVS Health Corp $NYSE:CVS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:CVS's 10-Y Financials

Financials (Next Earnings Date: 2017-05-09 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

CVS Guru Trades in Q1 2016

Murray Stahl 3,090 sh (New)
Dodge & Cox 2,630 sh (New)
Jim Simons 195,105 sh (New)
Joel Greenblatt 220,252 sh (New)
Steven Cohen 115,300 sh (New)
Ken Fisher 142,324 sh (+16.37%)
George Soros 27,511 sh (+5.93%)
Pioneer Investments 5,363,313 sh (+5.52%)
Manning & Napier Advisors, Inc 87,090 sh (+0.92%)
Mario Gabelli 1,188,900 sh (+0.86%)
Jeremy Grantham 2,319,096 sh (+0.79%)
RS Investment Management 792,755 sh (+0.58%)
Richard Pzena 528,659 sh (+0.24%)
PRIMECAP Management 3,548,780 sh (+0.10%)
Tom Gayner 247,000 sh (unchged)
Robert Olstein 64,000 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Paul Tudor Jones 47,500 sh (unchged)
Paul Tudor Jones 50,200 sh (unchged)
Vanguard Health Care Fund Sold Out
Barrow, Hanley, Mewhinney & Strauss Sold Out
Ray Dalio Sold Out
Paul Tudor Jones Sold Out
Jeff Auxier 52,349 sh (-0.29%)
Signature Select Canadian Fund 70,053 sh (-3.31%)
Scott Black 18,149 sh (-4.70%)
NWQ Managers 707,549 sh (-6.98%)
Charles de Vaulx 778,764 sh (-7.36%)
Ruane Cunniff 15,981 sh (-11.96%)
First Pacific Advisors 106,140 sh (-16.62%)
Mairs and Power 3,069 sh (-19.64%)
» More
Q2 2016

CVS Guru Trades in Q2 2016

Jerome Dodson 234,000 sh (New)
Ray Dalio 149,700 sh (New)
John Buckingham 43,573 sh (New)
Louis Moore Bacon 2,679 sh (New)
Paul Tudor Jones 33,167 sh (New)
Jim Simons 3,842,105 sh (+1869.25%)
Joel Greenblatt 652,002 sh (+196.03%)
George Soros 41,175 sh (+49.67%)
Robert Olstein 91,000 sh (+42.19%)
RS Investment Management 897,935 sh (+13.27%)
Murray Stahl 3,397 sh (+9.94%)
First Pacific Advisors 114,190 sh (+7.58%)
Pioneer Investments 5,751,921 sh (+7.25%)
Richard Pzena 529,884 sh (+0.23%)
Tom Gayner 247,000 sh (unchged)
Jeff Auxier 52,349 sh (unchged)
Mairs and Power 3,069 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Dodge & Cox Sold Out
Steven Cohen Sold Out
PRIMECAP Management 3,527,170 sh (-0.61%)
Manning & Napier Advisors, Inc 86,530 sh (-0.64%)
Charles de Vaulx 753,827 sh (-3.20%)
Mario Gabelli 1,139,978 sh (-4.11%)
Scott Black 17,206 sh (-5.20%)
Ruane Cunniff 14,856 sh (-7.04%)
Ken Fisher 129,783 sh (-8.81%)
NWQ Managers 607,584 sh (-14.13%)
Jeremy Grantham 1,825,963 sh (-21.26%)
» More
Q3 2016

CVS Guru Trades in Q3 2016

David Dreman 9,185 sh (New)
Barrow, Hanley, Mewhinney & Strauss 9,100,036 sh (New)
Steven Cohen 82,162 sh (New)
John Paulson 122,200 sh (New)
Eaton Vance Worldwide Health Sciences Fund 228,705 sh (New)
NWQ Managers 933,958 sh (+53.72%)
Scott Black 23,496 sh (+36.56%)
Robert Olstein 108,000 sh (+18.68%)
First Pacific Advisors 131,530 sh (+15.19%)
Jerome Dodson 256,000 sh (+9.40%)
Ken Fisher 132,741 sh (+2.28%)
Manning & Napier Advisors, Inc 87,010 sh (+0.55%)
Richard Pzena 529,858 sh (unchged)
Tom Gayner 247,000 sh (unchged)
George Soros 689,500 sh (unchged)
Ray Dalio Sold Out
Louis Moore Bacon Sold Out
George Soros Sold Out
Jeff Auxier 52,199 sh (-0.29%)
PRIMECAP Management 3,492,690 sh (-0.98%)
John Buckingham 42,964 sh (-1.40%)
Pioneer Investments 5,533,119 sh (-3.80%)
Mairs and Power 2,949 sh (-3.91%)
Murray Stahl 3,197 sh (-5.89%)
Mario Gabelli 1,065,457 sh (-6.54%)
Charles de Vaulx 703,490 sh (-6.68%)
Ruane Cunniff 13,801 sh (-7.10%)
Signature Select Canadian Fund 58,903 sh (-15.92%)
Joel Greenblatt 440,659 sh (-32.41%)
Jeremy Grantham 1,144,482 sh (-37.32%)
Jim Simons 940,005 sh (-75.53%)
Paul Tudor Jones 6,831 sh (-79.40%)
» More
Q4 2016

CVS Guru Trades in Q4 2016

Arnold Van Den Berg 69,740 sh (New)
Richard Snow 3,995 sh (New)
Ray Dalio 109,013 sh (New)
Wallace Weitz 121,162 sh (New)
John Rogers 33,499 sh (New)
Paul Tudor Jones 28,945 sh (+323.73%)
Joel Greenblatt 1,055,841 sh (+139.61%)
Manning & Napier Advisors, Inc 190,110 sh (+118.49%)
Barrow, Hanley, Mewhinney & Strauss 18,280,528 sh (+100.88%)
Charles de Vaulx 1,384,235 sh (+96.77%)
NWQ Managers 1,352,559 sh (+44.82%)
Pioneer Investments 7,679,466 sh (+38.79%)
Steven Cohen 112,900 sh (+37.41%)
Robert Olstein 140,000 sh (+29.63%)
First Pacific Advisors 161,800 sh (+23.01%)
Jeff Auxier 62,049 sh (+18.87%)
John Buckingham 45,261 sh (+5.35%)
Scott Black 24,241 sh (+3.17%)
Ken Fisher 134,917 sh (+1.64%)
Richard Pzena 533,748 sh (+0.73%)
Mario Gabelli 1,071,617 sh (+0.58%)
Tom Gayner 248,000 sh (+0.40%)
John Paulson Sold Out
Eaton Vance Worldwide Health Sciences Fund Sold Out
Jeremy Grantham 1,140,718 sh (-0.33%)
Mairs and Power 2,879 sh (-2.37%)
PRIMECAP Management 3,409,100 sh (-2.39%)
Ruane Cunniff 13,401 sh (-2.90%)
David Dreman 8,061 sh (-12.24%)
Murray Stahl 2,767 sh (-13.45%)
Jim Simons 724,505 sh (-22.93%)
Jerome Dodson 186,000 sh (-27.34%)
» More
» Details

Insider Trades

Latest Guru Trades with CVS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 621399    SIC: 8099
Compare:NYSE:AET, NAS:ESRX, NYSE:CI, NYSE:HUM, NYSE:ANTX, NYSE:CNC, NYSE:WCG, NYSE:UNH, NYSE:MOH, OTCPK:ODPVY, NAS:MGLN, NYSE:UAM, NAS:HIIQ, NAS:CNXR, OTCPK:OPRX, OTCPK:WCUI » details
Traded in other countries:CVSH34.Brazil, CVS.Chile, CVS.Germany, CVS.Mexico,
CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

CVS Health combines one of the largest retail pharmacy chains in the United States with one of the largest pharmacy benefit managers. The company processes approximately 1.3 billion prescriptions per year and operates more than 10,000 retail pharmacies across the U.S.

Ratios

vs
industry
vs
history
PE Ratio 15.99
CVS's PE Ratio is ranked higher than
70% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.66 vs. CVS: 15.99 )
Ranked among companies with meaningful PE Ratio only.
CVS' s PE Ratio Range Over the Past 10 Years
Min: 10.58  Med: 17.99 Max: 27.17
Current: 15.99
10.58
27.17
Forward PE Ratio 13.40
CVS's Forward PE Ratio is ranked higher than
70% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.51 vs. CVS: 13.40 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 15.95
CVS's PE Ratio without NRI is ranked higher than
75% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.10 vs. CVS: 15.95 )
Ranked among companies with meaningful PE Ratio without NRI only.
CVS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 10.62  Med: 17.9 Max: 27.17
Current: 15.95
10.62
27.17
Price-to-Owner-Earnings 11.58
CVS's Price-to-Owner-Earnings is ranked higher than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.64 vs. CVS: 11.58 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CVS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.07  Med: 20.5 Max: 60.4
Current: 11.58
9.07
60.4
PB Ratio 2.26
CVS's PB Ratio is ranked higher than
64% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.52 vs. CVS: 2.26 )
Ranked among companies with meaningful PB Ratio only.
CVS' s PB Ratio Range Over the Past 10 Years
Min: 1.01  Med: 1.79 Max: 3.37
Current: 2.26
1.01
3.37
PS Ratio 0.48
CVS's PS Ratio is ranked higher than
74% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.60 vs. CVS: 0.48 )
Ranked among companies with meaningful PS Ratio only.
CVS' s PS Ratio Range Over the Past 10 Years
Min: 0.4  Med: 0.6 Max: 0.89
Current: 0.48
0.4
0.89
Price-to-Free-Cash-Flow 10.81
CVS's Price-to-Free-Cash-Flow is ranked higher than
68% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.97 vs. CVS: 10.81 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CVS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.96  Med: 20.89 Max: 105.03
Current: 10.81
8.96
105.03
Price-to-Operating-Cash-Flow 8.42
CVS's Price-to-Operating-Cash-Flow is ranked higher than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.04 vs. CVS: 8.42 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CVS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.72  Med: 12.81 Max: 19.27
Current: 8.42
6.72
19.27
EV-to-EBIT 10.77
CVS's EV-to-EBIT is ranked higher than
67% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.01 vs. CVS: 10.77 )
Ranked among companies with meaningful EV-to-EBIT only.
CVS' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.6  Med: 11.4 Max: 20.4
Current: 10.77
7.6
20.4
EV-to-EBITDA 8.58
CVS's EV-to-EBITDA is ranked higher than
64% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.47 vs. CVS: 8.58 )
Ranked among companies with meaningful EV-to-EBITDA only.
CVS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.2  Med: 9.15 Max: 16
Current: 8.58
6.2
16
PEG Ratio 1.13
CVS's PEG Ratio is ranked higher than
71% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.93 vs. CVS: 1.13 )
Ranked among companies with meaningful PEG Ratio only.
CVS' s PEG Ratio Range Over the Past 10 Years
Min: 0.56  Med: 1.31 Max: 2.48
Current: 1.13
0.56
2.48
Shiller PE Ratio 23.27
CVS's Shiller PE Ratio is ranked higher than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 26.26 vs. CVS: 23.27 )
Ranked among companies with meaningful Shiller PE Ratio only.
CVS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.19  Med: 25.16 Max: 39.08
Current: 23.27
17.19
39.08
Current Ratio 1.18
CVS's Current Ratio is ranked higher than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.18 vs. CVS: 1.18 )
Ranked among companies with meaningful Current Ratio only.
CVS' s Current Ratio Range Over the Past 10 Years
Min: 1.18  Med: 1.52 Max: 1.93
Current: 1.18
1.18
1.93
Quick Ratio 0.62
CVS's Quick Ratio is ranked lower than
76% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.97 vs. CVS: 0.62 )
Ranked among companies with meaningful Quick Ratio only.
CVS' s Quick Ratio Range Over the Past 10 Years
Min: 0.35  Med: 0.58 Max: 0.93
Current: 0.62
0.35
0.93
Days Inventory 34.96
CVS's Days Inventory is ranked lower than
67% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.25 vs. CVS: 34.96 )
Ranked among companies with meaningful Days Inventory only.
CVS' s Days Inventory Range Over the Past 10 Years
Min: 34.96  Med: 41.44 Max: 50.81
Current: 34.96
34.96
50.81
Days Sales Outstanding 25.01
CVS's Days Sales Outstanding is ranked higher than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.70 vs. CVS: 25.01 )
Ranked among companies with meaningful Days Sales Outstanding only.
CVS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.77  Med: 22.19 Max: 28.31
Current: 25.01
18.77
28.31
Days Payable 19.51
CVS's Days Payable is ranked lower than
71% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 51.64 vs. CVS: 19.51 )
Ranked among companies with meaningful Days Payable only.
CVS' s Days Payable Range Over the Past 10 Years
Min: 16.69  Med: 19.59 Max: 21.78
Current: 19.51
16.69
21.78

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.26
CVS's Dividend Yield % is ranked higher than
76% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.47 vs. CVS: 2.26 )
Ranked among companies with meaningful Dividend Yield % only.
CVS' s Dividend Yield % Range Over the Past 10 Years
Min: 0.42  Med: 1.15 Max: 2.26
Current: 2.26
0.42
2.26
Dividend Payout Ratio 0.35
CVS's Dividend Payout Ratio is ranked lower than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.33 vs. CVS: 0.35 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CVS' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11  Med: 0.2 Max: 0.35
Current: 0.35
0.11
0.35
3-Year Dividend Growth Rate 23.60
CVS's 3-Year Dividend Growth Rate is ranked higher than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. CVS: 23.60 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CVS' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 19.9 Max: 37
Current: 23.6
0
37
Forward Dividend Yield % 2.55
CVS's Forward Dividend Yield % is ranked higher than
81% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.47 vs. CVS: 2.55 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 7.77
CVS's 5-Year Yield-on-Cost % is ranked lower than
61% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.32 vs. CVS: 7.77 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CVS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.44  Med: 3.94 Max: 7.77
Current: 7.77
1.44
7.77
3-Year Average Share Buyback Ratio 3.50
CVS's 3-Year Average Share Buyback Ratio is ranked higher than
74% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. CVS: 3.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CVS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -21.4  Med: -0.1 Max: 4.7
Current: 3.5
-21.4
4.7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.78
CVS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
78% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.17 vs. CVS: 0.78 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CVS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.78  Med: 1.64 Max: 13.38
Current: 0.78
0.78
13.38
Price-to-Intrinsic-Value-DCF (Earnings Based) 0.99
CVS's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
82% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.44 vs. CVS: 0.99 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.80
CVS's Price-to-Median-PS-Value is ranked higher than
70% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.14 vs. CVS: 0.80 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CVS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.7  Med: 1 Max: 2.43
Current: 0.8
0.7
2.43
Price-to-Peter-Lynch-Fair-Value 1.16
CVS's Price-to-Peter-Lynch-Fair-Value is ranked higher than
58% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.52 vs. CVS: 1.16 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CVS' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.65  Med: 1.54 Max: 5.14
Current: 1.16
0.65
5.14
Earnings Yield (Greenblatt) % 9.29
CVS's Earnings Yield (Greenblatt) % is ranked higher than
74% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.13 vs. CVS: 9.29 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CVS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.9  Med: 8.8 Max: 13.2
Current: 9.29
4.9
13.2
Forward Rate of Return (Yacktman) % 19.62
CVS's Forward Rate of Return (Yacktman) % is ranked higher than
67% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.62 vs. CVS: 19.62 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CVS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 11.3  Med: 17.95 Max: 24.2
Current: 19.62
11.3
24.2

More Statistics

Revenue (TTM) (Mil) $177,526
EPS (TTM) $ 4.91
Beta0.67
Short Percentage of Float2.96%
52-Week Range $69.30 - 106.67
Shares Outstanding (Mil)1,025.70

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 185,409 196,227 205,799
EPS ($) 5.75 6.23 6.85
EPS without NRI ($) 5.75 6.23 6.85
EPS Growth Rate
(Future 3Y To 5Y Estimate)
13.43%
Dividends per Share ($) 1.84 2.44 2.91
» More Articles for NYSE:CVS

Headlines

Articles On GuruFocus.com
Arnold Van Den Berg Invests in 4 New Buys in 4th Quarter Mar 13 2017 
Pioneer Investments Boosts JPMorgan, BlackRock, Comcast Mar 08 2017 
Is Troubled Retailer a Valid Value Stock? Feb 10 2017 
Weitz Funds Comments on CVS Health Jan 26 2017 
7 Stocks With Strong Yields Jan 17 2017 
December Magic Diligence Stock of the Month: CVS Health Dec 22 2016 
David Dreman Gains, Increases Multiple Positions in 3rd Quarter Dec 21 2016 
6 Worthy Dividend Stocks Down 10% or More Nov 22 2016 
Does the Increase in Volatility Signal a Dangerous Market Environment? Nov 11 2016 
CVS Not in the Pink After Earnings Call Nov 09 2016 

More From Other Websites
Keller Rohrback L.L.P. Files Class-Action Lawsuit Over the Inflated Price of Insulin Mar 25 2017
19 Retailers Are Shedding Stores So Far in 2017 Mar 24 2017
16 Large Retailers Besides J.C. Penney Are Closing Waves of Stores Mar 24 2017
CVS Lease-Backed Pass-Through Certificates, Series 2003-1 -- Moody's Affirms 12 CVS Lease Backed... Mar 23 2017
CVS Credit Lease Backed Pass-Through Certificates, Series A-1 and Series A-2 -- Moody's Affirms the... Mar 23 2017
CVS Health, University of Pittsburgh School of Pharmacy and Pittsburgh Public Schools Announce Joint... Mar 23 2017
Retail CFOs Expect 5% Sales Growth This Year Mar 22 2017
Pharmacy Benefit Managers and Insulin Makers Face Price Scheme Lawsuit Mar 22 2017
Is The Market Expensive? Buffett Says No Mar 20 2017
CVS Health says Amgen data may increase eligible patients by millions Mar 17 2017
CVS Health Corp. : CVS-US: Dividend Analysis : January 24th, 2017 (record date) : By the numbers :... Mar 17 2017
CVS Health Launches Reduced Rx for Affordable Medication Mar 17 2017
CVS Health Launches Reduced Rx™ Savings Program to Give Patients Access to More Affordable... Mar 16 2017
CVS Health (CVS) Up 4% Since Earnings Report: Can It Continue? Mar 16 2017
Express Scripts Downgraded On Fear It Could Lose Anthem Contract Mar 15 2017
Walgreens to Sell Assets to Acquire Rite Aid Mar 15 2017
CVS Health PBM Clients Achieved Lowest Prescription Drug Trend in Four Years, Despite Rising Drug... Mar 15 2017
Longs Drugs to open another pharmacy at Ala Moana Center Mar 14 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)